Nanayakkara Senarath Appuhamilage Samanthi Nisansala Senarath

Nanayakkara Senarath Appuhamilage Samanthi Nisansala Senarath

Auto-generated profile, based on publicly available information

Nanayakkara Senarath Appuhamilage Samanthi Nisansala Senarath

University of Sri Jayewardenepura

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2025 in International Journal of Risk & Safety in Medicine
Verified
Journal Article
Closed access
NSNsasn Senarath
Nsasn Senarath
DSD De Silva
D De Silva
RRRwmwk Rathnayake
Rwmwk Rathnayake
SWSsp Warnakulasuriya
Ssp Warnakulasuriya
MMMkdl Meegoda
Mkdl Meegoda
SJSs Jayasinghe
Ss Jayasinghe
Background: Chemotherapy is a well-known treatment modality against cancer. Occupational exposure to chemotherapy and related adverse effects are widely reported. Safe handling is vital in the reduction of possible risks. Objective: To assess perceptions of occupational exposure and adherence to safety measures of handling Systemic Anti-Cancer Therapy (SACT) among nurses. Methods: A phenomenological study was carried out using a semi-structured, in-depth interviewer guide following the Health Belief Model (HBM) components. The study adopted a purposive sampling method, and data was collected until it reached the saturation point. A thematic analysis was carried out, preserving the study’s trustworthiness. Results: The nurse’s main role was to administer chemotherapy. The primary learning sources were clinical experience and follow-up with seniors. Nurses accept that they are occupationally exposed to chemotherapy and believe that safety measures are protective against exposure. Surgical gloves and masks were common PPE, and chemotherapy-specific masks and gowns were mainly used in mixing drugs. Staffing, safe work practices, separate waste disposal, and seniors’ guidance are identified as protective measures. Headache, vomiting, hair loss, skin irritation, and miscarriages were commonly perceived as adverse effects of handling SACT. Conclusions: An increased patient count, frequent complex doses, a lack of PPE and facilities, and discomfort with PPE might increase exposure.

19 November 2025 in Research Square
Verified
Preprint
Open access
PDF file
SWSudath Shirley Pathmasiri Warnakulasuriya
Sudath Shirley Pathmasiri Warnakulasuriya
MMMeegoda Kankanange Dona Lalitha Meegoda
Meegoda Kankanange Dona Lalitha Meegoda
SJSudheera Sammanthi Jayasinghe
Sudheera Sammanthi Jayasinghe
DSDarshan Sri Indrajith Dammika De Silva
Darshan Sri Indrajith Dammika De Silva
RRRathnayake Rathnayake
Rathnayake Rathnayake
NSNanayakkara Senarath Appuhamilage Samanthi Nisansala Senarath
Nanayakkara Senarath Appuhamilage Samanthi Nisansala Senarath
Background Despite the therapeutic effectiveness against cancer, Systemic Anti-Cancer Therapy (SACT) causes a wide range of adverse effects (AEs) among both patients and healthcare workers (HCWs). Methods A retrospective cohort and comparative study were conducted among randomly selected patients (n = 400) and HCWs (n = 360), including nurses, pharmacists, doctors, attendants, and cleaning staff. AEs among HCWs were compared with those in the control group (n = 420). A 50-item structured questionnaire was used to assess the prevalence, frequency, severity, and distress caused by AEs. Results A higher mean number of AEs was reported by patients (17.49 ± 2.87) and exposure group nurses (4.53 ± 2.58). Headaches, dizziness, drowsiness, nausea, skin and ocular irritation, and hair loss are more common among both patients and HCWs. The prevalence of common AEs was associated with the selected patient characteristics, and 75% of patients reported more than sixteen of the twenty common AEs. Among HCWs, nurses in the exposure group reported reproductive-related AEs, and the prevalence of AEs varied significantly across the occupational categories. Conclusions The findings of the study indicate that SACT is associated with a broad spectrum of AEs affecting both patients and HCWs. Therefore, effective strategies are required to manage SACT-associated AEs among patients and to strengthen occupational health and safety measures for HCWs exposed to SACT.